Bayer Says Number of Roundup Plaintiffs Rose as Coronavirus Slows Down Mediation
27 Aprile 2020 - 09:23AM
Dow Jones News
By Kim Richters
Bayer AG on Monday reported a rise in plaintiffs in connection
with its glyphosate-based weedkiller Roundup, and said that the
related mediation process has slowed down due to the coronavirus
pandemic.
The German pharmaceutical and chemical company said it is facing
lawsuits from around 52,500 plaintiffs as of April 14, up from
around 48,600 plaintiffs reported in its fourth-quarter
earnings.
The plaintiffs are claiming that Bayer's Roundup herbicides
cause cancer, while Bayer has argued that Roundup and its
ingredient glyphosate are safe.
Bayer said it is continuing to "engage constructively in the
mediation process and had made progress" before the coronavirus
pandemic slowed it down.
"The company will continue to consider a solution only if it is
financially reasonable and puts in place a mechanism to resolve
potential future claims efficiently. Against the background of a
looming recession and looking at, in part, considerable liquidity
challenges, this applies now more than ever," said the company's
Chief Executive Werner Baumann.
The company on Monday reported a rise in first-quarter sales and
earnings.
Write to Kim Richters at kim.richters@wsj.com
(END) Dow Jones Newswires
April 27, 2020 03:08 ET (07:08 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Grafico Azioni Bayer (TG:BAYN)
Storico
Da Feb 2024 a Mar 2024
Grafico Azioni Bayer (TG:BAYN)
Storico
Da Mar 2023 a Mar 2024